Showing results (31-40 of 49) with videos related to

Sort By:
Pageof 5
Journal of Clinical Pharmacology|May 1, 2023
Utilization of a Population Pharmacokinetic Model to Improve a Busulfan Test-Dose Strategy in Allogeneic Hematopoietic Cell Transplant RecipientsTyler C Dunlap, Daniel L Weiner, Ryan M Kemper, et al.
Molecules (Basel, Switzerland)|October 13, 2021
Synthesis and Evaluation of Novel 1,2,6-Thiadiazinone Kinase Inhibitors as Potent Inhibitors of Solid TumorsAndreas S Kalogirou, Michael P East, Tuomo Laitinen, et al.
The Annals of Pharmacotherapy|September 20, 2021
Response to Tyrosine Kinase Inhibitors in Real-World Patients With Chronic Myeloid LeukemiaAndy H Szeto, Tyler Bucci, Allison Deal, et al.
Cancer Research|November 3, 2018
Genetic Variants of <i>VEGFA</i> and <i>FLT4</i> Are Determinants of Survival in Renal Cell Carcinoma Patients Treated with SorafenibDaniel J Crona, Andrew D Skol, Veli-Matti Leppänen, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|August 18, 2021
Pharmacokinetics of perioperative FVIII in adult patients with haemophilia A: An external validation and development of an alternative population pharmacokinetic modelJing Zhu, Yi Shuan Wu, Ryan J Beechinor, et al.
Kidney International Reports|April 30, 2025
Erratum to "Anticoagulation for the Prevention of Thrombotic Events in Nephrotic Syndrome" [<i>Kidney International Reports</i> Volume 9, Issue 10, October 2024, Pages 3053-3056]David Massicotte-Azarniouch, Daniel J Crona, Priscilla Karnabi, et al.
Urologic Oncology|October 22, 2016
Phase 1/2 multiple ascending dose trial of the prostate-specific membrane antigen-targeted antibody drug conjugate MLN2704 in metastatic castration-resistant prostate cancerMatthew I Milowsky, Matthew D Galsky, Michael J Morris, et al.
Clinical and Translational Science|January 27, 2021
Evaluation of the performance of a prior tacrolimus population pharmacokinetic kidney transplant model among adult allogeneic hematopoietic stem cell transplant patientsJing Zhu, Olivia Campagne, Chad D Torrice, et al.
Plos One|December 31, 2021
Correction: A real-world evaluation of radium-223 in combination with abiraterone or enzalutamide for the treatment of metastatic castration-resistant prostate cancerStephanie I Kim, Andy H Szeto, Katherine P Morgan, et al.
Plos One|June 21, 2021
A real-world evaluation of radium-223 in combination with abiraterone or enzalutamide for the treatment of metastatic castration-resistant prostate cancerStephanie I Kim, Andy H Szeto, Katherine P Morgan, et al.
Pageof 5